Literature DB >> 25178647

Metformin in women with PCOS, cons.

Marie L Misso1, Helena J Teede.   

Abstract

Metformin has a potential role for insulin resistance in polycystic ovary syndrome(PCOS) and has demonstrated efficacy in diabetes. There are a large number of studies and evidence syntheses comparing metformin with control, lifestyle interventions, the oral contraceptive pill, and clomiphene citrate; however, there is still uncertainty about the effectiveness of metformin in women with PCOS. Here we present a systematic overview of the evidence for the use of metformin in women with PCOS. The evidence suggests that metformin continues to have an unclear roll in PCOS until further well designed; methodologically rigorous effectiveness studies with large sample sizes are conducted, and these should include women across the body mass index (BMI) range.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25178647     DOI: 10.1007/s12020-014-0394-8

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  44 in total

1.  Metformin versus lifestyle changes in treating women with polycystic ovary syndrome.

Authors:  Daniella D G Curi; Angela Maggio Fonseca; José Antônio M Marcondes; José Alcione M Almeida; Vicente R Bagnoli; José Maria Soares; Edmund Chada Baracat
Journal:  Gynecol Endocrinol       Date:  2012-02-06       Impact factor: 2.260

Review 2.  Insulin-sensitising drugs versus the combined oral contraceptive pill for hirsutism, acne and risk of diabetes, cardiovascular disease, and endometrial cancer in polycystic ovary syndrome.

Authors:  M Costello; B Shrestha; J Eden; P Sjoblom; N Johnson
Journal:  Cochrane Database Syst Rev       Date:  2007-01-24

3.  Effect of metformin on ovulation and reproductive outcomes in women with polycystic ovary syndrome: a meta-analysis of randomized controlled trials.

Authors:  Xiaoli Sun; Dan Zhang; Wei Zhang
Journal:  Arch Gynecol Obstet       Date:  2013-02-21       Impact factor: 2.344

4.  Preliminary indication of a high prevalence of polycystic ovary syndrome in indigenous Australian women.

Authors:  S R Davis; S Knight; V White; C Claridge; B J Davis; R Bell
Journal:  Gynecol Endocrinol       Date:  2002-12       Impact factor: 2.260

5.  Metformin is a reasonable first-line treatment option for non-obese women with infertility related to anovulatory polycystic ovary syndrome--a meta-analysis of randomised trials.

Authors:  Neil Johnson
Journal:  Aust N Z J Obstet Gynaecol       Date:  2011-01-28       Impact factor: 2.100

6.  Effects of medical therapy on insulin resistance and the cardiovascular system in polycystic ovary syndrome.

Authors:  Caroline Meyer; Barry P McGrath; Helena Jane Teede
Journal:  Diabetes Care       Date:  2007-03       Impact factor: 19.112

Review 7.  Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications.

Authors:  Evanthia Diamanti-Kandarakis; Andrea Dunaif
Journal:  Endocr Rev       Date:  2012-10-12       Impact factor: 19.871

8.  Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic-hyperinsulaemic clamp.

Authors:  Nigel K Stepto; Samantha Cassar; Anju E Joham; Samantha K Hutchison; Cheryce L Harrison; Rebecca F Goldstein; Helena J Teede
Journal:  Hum Reprod       Date:  2013-01-12       Impact factor: 6.918

Review 9.  Metformin versus clomiphene citrate for infertility in non-obese women with polycystic ovary syndrome: a systematic review and meta-analysis.

Authors:  Marie L Misso; Michael F Costello; Marie Garrubba; Jennifer Wong; Roger Hart; Luk Rombauts; Angela M Melder; Robert J Norman; Helena J Teede
Journal:  Hum Reprod Update       Date:  2012-09-06       Impact factor: 15.610

10.  Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group.

Authors:  Bart C J M Fauser; Basil C Tarlatzis; Robert W Rebar; Richard S Legro; Adam H Balen; Roger Lobo; Enrico Carmina; Jeffrey Chang; Bulent O Yildiz; Joop S E Laven; Jacky Boivin; Felice Petraglia; C N Wijeyeratne; Robert J Norman; Andrea Dunaif; Stephen Franks; Robert A Wild; Daniel Dumesic; Kurt Barnhart
Journal:  Fertil Steril       Date:  2011-12-06       Impact factor: 7.329

View more
  2 in total

Review 1.  Metformin: New Preparations and Nonglycemic Benefits.

Authors:  Yoshihito Fujita; Nobuya Inagaki
Journal:  Curr Diab Rep       Date:  2017-01       Impact factor: 4.810

Review 2.  Myo-Inositol's Role in Assisted Reproductive Technology: Evidence for Improving the Quality of Oocytes and Embryos in Patients With Polycystic Ovary Syndrome.

Authors:  Deepti Gupta; Safeera Khan; Muhammad Islam; Bilal Haider Malik; Ian H Rutkofsky
Journal:  Cureus       Date:  2020-05-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.